BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21569097)

  • 1. Evaluation of disk diffusion methods to detect low-level β-lactamase-negative ampicillin-resistant Haemophilus influenzae.
    Nørskov-Lauritsen N; Ridderberg W; Erikstrup LT; Fuursted K
    APMIS; 2011 Jun; 119(6):385-92. PubMed ID: 21569097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
    Shelton MM; Welch DF
    Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
    Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG
    CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of susceptibility of Haemophilus influenzae to beta-lactams by using HTM gelose (Haemophilus test medium)].
    Dabernat H; Seguy M; Delmas C
    Pathol Biol (Paris); 1993 Sep; 41(7):589-95. PubMed ID: 8255610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Haemophilus influenzae and Haemophilus parainfluenzae susceptibility to ampicillin and other antibiotics.
    Urbásková P; Thuy HT
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):93-104. PubMed ID: 1619296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Haemophilus influenzae and Haemophilus parainfluenzae to beta-lactam antibiotics. Characterization of the beta-lactamases].
    Tirado M; Baró MT; Hermida M; Morta M; Alia C; Roy C
    Enferm Infecc Microbiol Clin; 1992; 10(6):355-9. PubMed ID: 1391019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of antibacterial agents on Haemophilus influenzae isolates.
    Chugh TD; Neil L; Mahboob AG; Araj GF
    Trop Geogr Med; 1986 Dec; 38(4):404-7. PubMed ID: 3492795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid method for determining antimicrobial susceptibility of Haemophilus influenzae.
    Smith JA; Ngui-Yen JH; Fothergill J; Porter D
    J Clin Microbiol; 1982 Nov; 16(5):832-5. PubMed ID: 6984049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiclonal Expansion and High Prevalence of β-Lactamase-Negative Haemophilus influenzae with High-Level Ampicillin Resistance in Japan and Susceptibility to Quinolones.
    Honda H; Sato T; Shinagawa M; Fukushima Y; Nakajima C; Suzuki Y; Shiraishi T; Kuronuma K; Takahashi S; Takahashi H; Yokota SI
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
    Powell M; Williams JD
    J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampicillin susceptibility testing of Haemophilus influenzae in the routine clinical laboratory by the EUCAST methodology compared to broth microdilution and the presence of ftsI gene mutations.
    Sturm PDJ; Hermans NTH; van der Zanden AGM; Peters CJA; Schülin T
    Clin Microbiol Infect; 2024 Jul; 30(7):952.e1-952.e4. PubMed ID: 38554928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
    Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016.
    Potts CC; Rodriguez-Rivera LD; Retchless AC; Buono SA; Chen AT; Marjuki H; Blain AE; Wang X
    Microbiol Spectr; 2022 Jun; 10(3):e0257921. PubMed ID: 35536039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
    Fuchs PC; Barry AL
    J Clin Microbiol; 1994 Nov; 32(11):2846-50. PubMed ID: 7852584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.
    Doern GV; Jorgensen JH; Thornsberry C; Preston DA
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):95-107. PubMed ID: 3485505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL; Fuchs PC; Pfaller MA
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO; Gezelius L
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.
    Burns JL; Wong K; Smith AL
    Infection; 1988; 16(5):293-6. PubMed ID: 3265130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD; Powell M; Fah YS; Seymour A; Yuan M
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.